(D O): d 53.9, 51.6, 46.5, 45.2, (CH N), 20.7 (CH CH CH ).
Compound 8f. White powder (90%). 13C NMR (D O): d
2
2
2
2
2
2
138.9, 138.2, 133.8, 131.5 (C ), 86.0, 85.9, 74.5 (C
), 64.3,
C H N É 6HCl É 4H O (675.43): calc. C 33.79, H 8.66, N
ar
aminal
19 44
8
2
63.7, 59.9, 59.8, 54.2, 51.2, 51.1, 50.4, 46.6 (CH N).
16.59, Cl 31.49; found C 33.51, H 8.62, N 16.44, Cl 31.28%.
1-[4-(1,4,7,10-T etraazacyclododecan-1-yl)butyl]-1,4,7,10-
tetraazacyclododecane (8ºi). White crystals (72%). 13C NMR
2
Compound 8g. White powder (95%). 13C NMR (D O): d
138.1, 135.0, (C ), 85.6, 74.4 (C
2
), 65.2, 60.1, 58.4, 54.2, 51.2,
ar
aminal
51.0, 50.7, 50.5, 46.4 (CH N).
(D O):
d
56.8, 52.3, 46.6, 45.8, 45.3 (CH N), 23.6
2
2
2
Compound 8h. White powder (80%). 13C NMR (D O): d
(CH CH CH CH ). C
H
N É 7HCl É 5H O (743.93): calc.
2
2
2
2
2
20 46
8
2
87.2, 74.4 (C
aminal
50.4, 46.5 (CH N), 21.0, (CH CH CH ).
), 65.2, 60.2, 60.1, 57.1, 54.1, 51.2, 51.0, 50.6,
C 32.29, H 8.54, N 15.06, Cl 33.36; found C 32.12, H 8.47, N
14.71, Cl 33.20%.
2
2
2
2
Compound 8i. White powder (78%). 13C NMR (D O): d
1-[5-(1,4,7,10-T etraazacyclododecan-1-yl)pentyl]-1,4,7,10-
tetraazacyclododecane (8ºj). White crystals (81%). 13C NMR
2
84.6, 72.4 (C
aminal
44.4 (CH N), 20.8 (CH CH CH CH ).
), 62.9, 58.0, 57.8, 52.0, 49.1, 48.9, 48.5, 48.3,
(D O):
d
57.9, 53.0, 46.4, 46.2, 45.3 (CH N), 28.2
2
2
2
2
2
2
2
Compound 8j. White powder (75%). 13C NMR (D O): d
(CH CH CH CH CH ),
25.7
(CH CH CH CH CH ).
2
2
H
2
8
2
2
2
2
2
2
2
2
2
86.6, 74.5 (C
), 65.0, 60.7, 59.8, 54.1, 51.3, 51.1, 50.6, 50.5,
C
N É 6HCl É 3H O (685.47): calc. C 36.80, H 8.82, N
aminal
21 48
46.6
(CH N),
25.8
(CH CH CH CH CH ),
25.3
16.35, Cl 31.03; found C 36.56, H 8.86, N 16.24, Cl 30.86%.
1-[4-(1,4,8,12-T etraazacyclopentadecan-1-ylmethyl)benzyl]-
1,4,8,12-tetraazacyclopentadecane (10ºe). White crystals (93%).
13C NMR (D O): d 135.0, 133.5, (C ), 61.8, 51.7, 48.9, 45.7,
2
2
2
2
2
2
(CH CH CH CH CH ).
2
2
2
2
2
Compound 9e. White powder (100%). 13C NMR (D O): d
2
137.0, 131.5 (C ), 85.2, 72.3 (C
54.2, 51.4, 49.4, 44.8 (CH N), 21.3, 20.9 (NCH CH ).
), 64.5, 62.9, 56.8, 56.1, 54.8,
ar
aminal
2
ar
44.9, 44.7, 44.3, 41.7 (CH N), 23.1, 22.7, 22.0
2
2
2
2
Compound 9f. White powder (85%). 13C NMR (D O): d
(NCH CH CH N). C
H
N É 6HCl É 4H O (821.66): calc. C
2
2
2
2
30 58
8
2
140.6, 138.6, 133.2, 129.9 (C ), 84.9, 72.3 (C
), 64.6, 62.7,
43.85, H 8.83, N 13.64, Cl 25.89; found C 44.02, H 8.82, N
13.72, Cl 26.01%.
ar
aminal
56.7, 56.2, 54.7, 54.2, 51.7, 49.4, 44.8 (CH N), 21.2, 20.8
2
(NCH CH ).
1-[5-(1,4,8,12-T etraazacyclopentadecan-1-yl)pentyl]-1,4,8,12-
2
2
Compound 9g. White powder (95%). 13C NMR (D O): d
tetraazacyclopentadecane (10ºj ). White crystals (95%). 13C
2
138.9, 133.8 (C ), 84.8, 72.3 (C
54.2, 51.6, 49.3, 44.8 (CH N), 21.4, 20.9 (NCH CH ).
), 63.1, 59.4, 56.7, 56.1, 54.8,
NMR (D O): d 58.5, 52.2, 49.5, 45.9, 45.0, 44.9, 44.5, 41.8,
ar
aminal
2
(CH N),
23.2, 22.8, 22.1 (NCH CH CH N), 26.2
2
2
2
2
2 2 2
(CH CH CH CH CH ).
Compound 9j. The low reactivity of cyclam glyoxal 2
towards 1,5-dibromopentane leads after evaporation of the
solvent to the sole monosalt 11j (vide infra).
Compound 10e. White powder (80%). 13C NMR (D O): d
136.7, 132.4 (C ), 86.0, 85.9, 78.2 (C
(CH CH CH CH CH ),
25.5
2
2
8
2
2
2
2
2
2
2
2
C
H
N É 6HCl É 4H O (787.64): calc. C 41.17, H 9.47, N
27 60
2
14.23, Cl 27.01; found C 41.33, H 9.44, N 14.32, Cl 27.11%.
2
Representative deprotection procedure with hydroxylamine.
Bis-cyclam 9 (1.4 mmol) was dissolved in 20 ml of dry ethanol
with 3 g of hydroxylamine hydrochloride and 2.9 g of sodium
ethoxide. The mixture was reÑuxed under nitrogen for 4 h.
After cooling, the solvent was evaporated, the resulting solid
was dissolved in 10 ml of 10 M NaOH and extracted four
times with chloroform. The combined organic phases were
evaporated and dropwise addition of an HClÈethanol solution
induced precipitation of the hydrochloride salt. Acetone was
then added to complete precipitation. After standing in a
refrigerator overnight, a white solid was Ðltered o†, washed
with acetone and dried in vacuo.
), 65.9, 59.7, 57.9, 55.5,
ar
aminal
54.5, 53.7, 53.4, 53.3, 49.0, 45.4 (CH N), 31.1, 25.0, 22.2
2
(NCH CH CH N).
2
2
2
Compound 10j. Soluble in CH CN, this compound was iso-
lated by evaporation of the solvent. The resulting solid was
3
washed with THF and dried in vacuo. White powder (88%).
13C NMR (D O): d 87.1, 77.5 (C
), 63.2, 60.2, 57.9, 55.6,
54.9, 53.5, 52.3, 49.3, 45.5 (CH N), 31.8, 25.0, 22.3
2
aminal
2
(NCH CH CH N), 25.8 (CH CH CH CH CH ), 23.3
2
2
2
2
2
2
2
2
(CH CH CH CH CH ).
2
2
2
2
2
Bis-salts deprotection: bis-macrocycles 8º,9º,10º
1-[4-(1,4,8,11-T etraazacyclotetradecan-1-ylmethyl)benzyl]-
1,4,8,11-tetraazacyclotetradecane (9ºe). White crystals (93%).
13C NMR (D O): d 135.0, 133.5 (C ), 61.4, 50.5, 47.2, 44.0,
Representative deprotection procedure in hydrazine mono-
hydrate. Compound 8 or 10 (4.6 mmol) and 20 ml of hydrazine
monohydrate were heated at 120 ¡C overnight. After cooling,
the solid was Ðltered, dissolved in ethanol and the solvent was
rotary evaporated. The solid was recrystallized in acetone and
precipitated as the hydrochloride salt for elemental analysis
and NMR spectra.
2
ar
43.8, 40.4, 39.9 (CH N), 21.4, 20.9 (NCH CH ).
2
2
2
C
H
N É 6HCl É 4H O (793.61): calc. C 42.38, H 8.64, N
28 54
8
2
14.12, Cl 26.80; found C 42.06, H 8.70, N 14.02, Cl 26.63%.
1-[3-(1,4,8,11-T etraazacyclotetradecan-1-ylmethyl)benzyl]-
1,4,8,11-tetraazacyclotetradecane (9ºf ). White crystals (91%).
13C NMR (D O): d 136.6, 136.1, 133.7, 132.3 (C ), 61.6, 50.5,
1-[4-(1,4,7,10-T etraazacyclododecan-1-ylmethyl)benzyl]-
1,4,7,10-tetraazacyclododecane (8ºe). White crystals (91%). 13C
NMR (D O): d 136.6, 133.8 (C ), 59.7, 51.1, 46.7, 45.1
2
ar
47.2, 44.3, 43.7, 40.4, 40.3, 39.8 (CH N), 21.3, 20.8 (NCH CH ).
2
2
2
C
H
N É 6HCl É 4H O (793.61): calc. C 42.38, H 8.64, N
28 54
8
2
2
(CH N). C
2
ar
14.12, Cl 26.80; found C 42.23, H 8.64, N 14.08, Cl 26.69%.
1-M[5-(1,4,8,11-T etraazacyclotetradecan-1-ylmethyl)-2-
H
N É 6HCl É 3H O (719.49): calc. C 40.06, H
24 46
8
2
8.13, N 15.57, Cl 29.57; found C 39.39, H 7.87, N 15.22, Cl
29.46%.
thienyl]methylN-1,4,8,11-tetraazacyclotetradecane (9ºg). White
crystals (88%). 13C NMR (D O): d 136.5, 136.0, (C ), 55.2,
1-[3-(1,4,7,10-T etraazacyclododecan-1-ylmethyl)benzyl]-
1,4,7,10-tetraazacyclododecane (8ºf ). White crystals (85%). 13C
NMR (D O): d 137.6, 135.1, 133.0, 132.4 (C ), 59.6, 50.8, 46.9,
2
ar
50.5, 47.4, 44.4, 44.1, 44.0, 40.8, 40.6, 40.5 (CH N), 21.6, 21.5
2
(NCH CH ).
C
H
N S É 6HCl É 3H O (781.62): calc.
C
2
2
26 52
8
2
2
ar
39.95, H 8.25, N 14.34, S 4.10, Cl 27.21; found C 39.53, H 8.27,
N 14.17, S 4.13, Cl 26.98%.
44.9, 44.8 (CH N). C
H
N É 7HCl É 4H O (773.96): calc. C
2
24 46
8
2
37.24, H 7.94, N 14.48, Cl 32.06; found C 37.27, H 7.67, N
14.04, Cl 31.94%.
Dissymmetrical bis-macrocycle syntheses
1-M[5-(1,4,7,10-T etraazacyclododecan-1-ylmethyl)-2-thienyl]-
methylN-1,4,7,10-tetraazacyclododecane (8ºg). White crystals
(90%). 13C NMR (D O): d 139.7, 132.2, (C ), 53.2, 50.1, 47.0,
Monosalts 11. Compound 11e. A solution of a,a@-dibromo-p-
xylene (1.18 g) in 10 ml of dry THF was added dropwise to a
THF solution of cyclam glyoxal 2 (1 g, 15 ml) and the mixture
was stirred for 10 days at room temperature. The precipitate
was Ðltered o†, washed with dry THF and dried in vacuo.
2
ar
45.0, 44.6 (CH N). C
H N S É 6HCl É 4H O (743.53): calc. C
2
22 44
8
2
35.54, H 7.86, N 15.07, S 4.31, Cl 28.61; found C 35.82, H 7.59,
N 15.04, S 4.37, Cl 28.40%.
1-[3-(1,4,7,10-T etraazacyclododecan-1-yl)propyl]-1,4,7,10-
tetraazacyclododecane (8ºh). White crystals (68%). 13C NMR
White solid (87%). 13C NMR (CDCl ): d 139.9, 134.1, 129.3,
3
126.5 (C ), 80.9, 69.5 (C
), 60.1, 58.2, 54.2, 54.1, 52.0,
ar
aminal
1172
New J. Chem., 2001, 25, 1168È1174